Genetic Variants of SARS-CoV-2—What Do They Mean?

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281 · see citing works

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,633 · see citing works

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557 · see citing works

Spike mutation D614G alters SARS-CoV-2 fitness

Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., et al. (2021) · Nature · doi:10.1038/s41586-020-2895-3 · Cited by 1,558 · see citing works

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Munnink, B. B. O., Sikkema, R. S., Nieuwenhuijse, D. F., Molenaar, R. J., Münger, E., Molenkamp, R., van der Spek, A. N., Tolsma, P., Rietveld, A., Brouwer, M., et al. (2020) · Science · doi:10.1126/science.abe5901 · Cited by 1,087 · see citing works

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O’Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.020 · Cited by 1,006 · see citing works

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science · doi:10.1126/science.abe8499 · Cited by 900 · see citing works

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.012 · Cited by 324 · see citing works

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityPreprint

Volz, E., Hill, V., McCrone, J., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20166082 · Cited by 313 · see citing works

We shouldn’t worry when a virus mutates during disease outbreaks

Grubaugh, N. D., Petrone, M. E., & Holmes, E. C. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0690-4 · Cited by 168 · see citing works

Detection of new SARS-CoV-2 variants related to mink

Adlhoch, C., Alm, E., Beauté, J., Broberg, E., Cenciarelli, O., Einöder-Moreno, M., Fleming, C., Gossner, C. M., Johansen, K., Mirinavičiūtė, G., et al. (2020) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 24 · see citing works

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343 · see citing works

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Lauring, A. S., Tenforde, M. W., Chappell, J. D., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Douin, D. J., Talbot, H. K., Casey, J. D., et al. (2022) · BMJ · doi:10.1136/bmj-2021-069761 · Cited by 656 · see citing works

Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants

Qu, L., Yi, Z., Shen, Y., Lin, L., Chen, F., Xu, Y., Wu, Z., Tang, H., Zhang, X., Tian, F., et al. (2021) · doi:10.1101/2021.03.16.435594 · Cited by 636 · see citing works

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Hodcroft, E. B., Zuber, M., Nadeau, S., Vaughan, T. G., Crawford, K. H. D., Althaus, C. L., Reichmuth, M. L., Bowen, J. E., Walls, A. C., Corti, D., et al. (2021) · Nature · doi:10.1038/s41586-021-03677-y · Cited by 425 · see citing works

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study

Frampton, D., Rampling, T., Cross, A., Bailey, H., Heaney, J., Byott, M., Scott, R., Sconza, R., Price, J., Margaritis, M., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00170-5 · Cited by 387 · see citing works

Emergence of a Novel SARS-CoV-2 Variant in Southern California

Zhang, W., Davis, B. D., Chen, S. S., Sincuir Martinez, J. M., Plummer, J. T., & Vail, E. (2021) · JAMA · doi:10.1001/jama.2021.1612 · Cited by 371 · see citing works

Global disparities in SARS-CoV-2 genomic surveillance

Brito, A. F., Semenova, E., Dudas, G., Hassler, G. W., Kalinich, C. C., Kraemer, M. U. G., Ho, J., Tegally, H., Githinji, G., Agoti, C. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33713-y · Cited by 351 · see citing works

Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

To, K. K., Sridhar, S., Chiu, K. H., Hung, D. L. L., Li, X., Hung, I. F., Tam, A. R., Chung, T. W., Chan, J. F., Zhang, J., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1898291 · Cited by 350 · see citing works

SARS-CoV-2 Variants, Vaccines, and Host Immunity

Mistry, P., Barmania, F., Mellet, J., Peta, K. T., Strydom, A., Viljoen, I. M., James, W., Gordon, S., & Pepper, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809244 · Cited by 293 · see citing works

Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm

Rabaan, A. A., Al-Ahmed, S. H., Muhammad, J., Khan, A., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Al‐Omari, A., Dhawan, M. K., et al. (2021) · Vaccines · doi:10.3390/vaccines9050436 · Cited by 255 · see citing works

Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2

Vogels, C. B. F., Breban, M. I., Ott, I. M., Alpert, T., Petrone, M. E., Watkins, A. E., Kalinich, C. C., Earnest, R., Rothman, J. E., de Jesus, J. G., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001236 · Cited by 223 · see citing works

Bacterial Coinfections in Coronavirus Disease 2019

Westblade, L. F., Simon, M. S., & Satlin, M. J. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.018 · Cited by 215 · see citing works

Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants

Tchesnokova, V. L., Kulasekara, H. D., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-21 · Cited by 210 · see citing works

Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike

Lubinski, B., Fernandes, M. H. V., Frazier, L. E., Tang, T., Daniel, S., Diel, D. G., Jaimes, J. A., & Whittaker, G. R. (2021) · iScience · doi:10.1016/j.isci.2021.103589 · Cited by 203 · see citing works

Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay

Ma, C., Sacco, M. D., Xia, Z., Lambrinidis, G., Townsend, J. A., Hu, Y., Meng, X., Szeto, T., Ba, M., Zhang, X., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00519 · Cited by 201 · see citing works

Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA

Earnest, R., Uddin, R., Matluk, N. N., Renzette, N., Turbett, S. E., Siddle, K. J., Loreth, C., Adams, G. C., Tomkins-Tinch, C. H., Petrone, M. E., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100583 · Cited by 200 · see citing works

Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know?

Vasireddy, D., Vanaparthy, R., Mohan, G., Malayala, S. V., & Atluri, P. (2021) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4518 · Cited by 197 · see citing works

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy

Giordano, G., Colaneri, M., Di Filippo, A., Blanchini, F., Bolzern, P., De Nicolao, G., Sacchi, P., Colaneri, P., & Bruno, R. (2021) · Nature Medicine · doi:10.1038/s41591-021-01334-5 · Cited by 192 · see citing works

Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies

Zhu, X. Q., Mannar, D., Srivastava, S. S., Berezuk, A., Demers, J., Saville, J. W., Leopold, K., Li, W., Dimitrov, D. S., Tuttle, K. S., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001237 · Cited by 176 · see citing works

SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications

Sharun, K., Dhama, K., PAWDE, A. M., Gortázar, C., Tiwari, R., Bonilla‐Aldana, D. K., Rodriguez-Morales, A. J., de la Fuente, J., Michalak, I., & Attia, Y. A. (2021) · Veterinary Quarterly · doi:10.1080/01652176.2021.1921311 · Cited by 169 · see citing works

Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus

Auriti, C., Rose, D. U. D., Santisi, A., Martini, L., Piersigilli, F., Bersani, I., Ronchetti, M. P., & Caforio, L. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166198 · Cited by 162 · see citing works

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations

Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801522 · Cited by 150 · see citing works

Public health actions to control new SARS-CoV-2 variants

Grubaugh, N. D., Hodcroft, E. B., Fauver, J. R., Phelan, A. L., & Cevik, M. (2021) · Cell · doi:10.1016/j.cell.2021.01.044 · Cited by 147 · see citing works

Evolutionary trajectory of SARS-CoV-2 and emerging variants

Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 144 · see citing works

Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England

Whitaker, M. D., Elliott, J., Bodinier, B., Barclay, W., Ward, H., Cooke, G., Donnelly, C. A., Chadeau‐Hyam, M., & Elliott, P. (2022) · Nature Communications · doi:10.1038/s41467-022-34244-2 · Cited by 143 · see citing works

Two Years into the COVID-19 Pandemic: Lessons Learned

da Silva, S. J. R., do Nascimento, J. C. F., Mendes, R. P. G., Guarines, K. M., da Silva, C. T. A., da Silva, P. G., de Magalhães, J. J. F., Vigar, J. R. J., Silva‐Júnior, A., Kohl, A., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00204 · Cited by 140 · see citing works

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

Becker, M., Dulovic, A., Junker, D., Ruétalo, N., Kaiser, P. D., Pinilla, Y. T., Heinzel, C., Häring, J., Traenkle, B., Wagner, T. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23473-6 · Cited by 135 · see citing works

SARS‐CoV‐2 variants and vulnerability at the global level

Chavda, V. P., Patel, A., & Vaghasiya, D. D. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27717 · Cited by 132 · see citing works

Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology

John, G., Sahajpal, N., Mondal, A. K., Ananth, S., Williams, C., Chaubey, A., Rojiani, A. M., & Kolhe, R. B. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43020061 · Cited by 123 · see citing works

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States

Alpert, T., Brito, A. F., Lasek‐Nesselquist, E., Rothman, J. E., Valesano, A. L., MacKay, M. J., Petrone, M. E., Breban, M. I., Watkins, A. E., Vogels, C. B. F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.061 · Cited by 120 · see citing works

The emerging SARS-CoV-2 variants of concern

Sanyaolu, A. O., Okorie, C., Marinkovic, A., Haider, N., Abbasi, A. F., Jaferi, U., Prakash, S., & Balendra, V. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211024372 · Cited by 120 · see citing works

Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis

Thye, A. Y.-K., Law, J. W., Pusparajah, P., Letchumanan, V., Chan, K., & Lee, L. (2021) · Biomedicines · doi:10.3390/biomedicines9101303 · Cited by 116 · see citing works

Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases

Lee, L., Samardzic, K., Wallach, M. G., Frumkin, L. R., & Mochly‐Rosen, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696003 · Cited by 114 · see citing works

Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677Preprint

Hodcroft, E. B., Domman, D., Snyder, D. J., Oguntuyo, K. Y., Diest, M. V., Densmore, K. H., Schwalm, K. C., Femling, J., Carroll, J. L., Scott, R. S., et al. (2021) · medRxiv · doi:10.1101/2021.02.12.21251658 · Cited by 109 · see citing works

COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns

Cabore, J. W., Karamagi, H. C., Kipruto, H. K., Mungatu, J. K., Asamani, J. A., Droti, B., Titi-ofei, R., Seydi, A. B. W., Kidane, S. N., Balde, T., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(22)00233-9 · Cited by 108 · see citing works

SARS-CoV-2 vaccines: a triumph of science and collaboration

Golob, J. L., Lugogo, N. L., Lauring, A. S., & Lok, A. S.-F. (2021) · JCI Insight · doi:10.1172/jci.insight.149187 · Cited by 106 · see citing works

The Emerging Concern and Interest SARS-CoV-2 Variants

Janik, E., Niemcewicz, M., Podogrocki, M., Majsterek, I., & Bijak, M. (2021) · Pathogens · doi:10.3390/pathogens10060633 · Cited by 106 · see citing works

Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis

Gong, F., Wei, H.-X., Li, Q., Liu, L., & Li, B. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.682405 · Cited by 103 · see citing works

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies

Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009772 · Cited by 99 · see citing works

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis

Raglow, Z., Surie, D., Chappell, J. D., Zhu, Y., Martin, E. T., Kwon, J. H., Frosch, A. E. P., Mohamed, A., Gilbert, J., Bendall, E. E., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00336-1 · Cited by 90 · see citing works

Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans

Haveri, A., Ekström, N., Solastie, A., Virta, C., Österlund, P., Isosaari, E., Nohynek, H., PALMU, A. A. I., & Melin, M. M. (2021) · European Journal of Immunology · doi:10.1002/eji.202149535 · Cited by 85 · see citing works

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses

Rabaan, A. A., Al-Ahmed, S. H., Garout, M. A., Al‐Qaaneh, A. M., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Hasan, A., Dhawan, M. K., et al. (2021) · Pathogens · doi:10.3390/pathogens10050565 · Cited by 84 · see citing works

A global picture: therapeutic perspectives for COVID-19

Chavda, V., Kapadia, C., Soni, S., Prajapati, R., Chauhan, S., Yallapu, M., & Apostolopoulos, V. (2022) · Immunotherapy · doi:10.2217/imt-2021-0168 · Cited by 66 · see citing works

Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Agoramoorthy, G., & Lee, S. (2021) · mBio · doi:10.1128/mbio.01140-21 · Cited by 83 · see citing works

Editorial: The XBB.1.5 (‘Kraken’) Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread

Parums, D. V. (2023) · Medical Science Monitor · doi:10.12659/msm.939580 · Cited by 83 · see citing works

Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update

Sankaran, D., Nakra, N. A., Cheema, R., Blumberg, D. A., & Lakshminrusimha, S. (2021) · NeoReviews · doi:10.1542/neo.22-5-e284 · Cited by 82 · see citing works

Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons

Chaguza, C., Coppi, A. C., Earnest, R., Ferguson, D. J. P., Kerantzas, N., Warner, F. J., Young, H. P., Breban, M. I., Billig, K., Koch, R. T., et al. (2022) · Med · doi:10.1016/j.medj.2022.03.010 · Cited by 81 · see citing works

Dynamics of a stochastic delay differential model for COVID-19 infection with asymptomatic infected and interacting people: Case study in the UAE

Rihan, F. A., & Alsakaji, H. J. (2021) · Results in Physics · doi:10.1016/j.rinp.2021.104658 · Cited by 77 · see citing works

Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo

Port, J. R., Yinda, C. K., Avanzato, V. A., Schulz, J. E., Holbrook, M. G., van Doremalen, N., Shaia, C., Fischer, R. J., & Munster, V. J. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01047-y · Cited by 77 · see citing works

Towards accurate and reliable resolution of structural variants for clinical diagnosis

Liu, Z., Roberts, R. A., Mercer, T. R., Xu, J., Sedlazeck, F. J., & Tong, W. (2022) · Genome biology · doi:10.1186/s13059-022-02636-8 · Cited by 77 · see citing works

SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression

Nemudryi, A. A., Nemudraia, A., Wiegand, T., Nichols, J. E., Snyder, D. T., Hedges, J. F., Cicha, C., Lee, H., Vanderwood, K. K., Bimczok, D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109197 · Cited by 76 · see citing works

Maximum likelihood pandemic-scale phylogenetics

Maio, N. D., Kalaghatgi, P., Turakhia, Y., Corbett-Detig, R. B., Minh, B. Q., & Goldman, N. (2023) · Nature Genetics · doi:10.1038/s41588-023-01368-0 · Cited by 72 · see citing works

SARS-CoV-2: is there neuroinvasion?

McQuaid, C., Brady, M., & Deane, R. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00267-y · Cited by 71 · see citing works

Microbicidal actives with virucidal efficacy against SARS-CoV-2 and other beta- and alpha-coronaviruses and implications for future emerging coronaviruses and other enveloped viruses

Ijaz, M. K., Nims, R. W., Zhou, S. S., Whitehead, K., Srinivasan, V., Kapes, T., Fanuel, S., Epstein, J. H., Daszak, P., Rubino, J. R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84842-1 · Cited by 66 · see citing works

Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern

Shahhosseini, N., Babuadze, G. G., Wong, G., & Kobinger, G. (2021) · Microorganisms · doi:10.3390/microorganisms9050926 · Cited by 66 · see citing works

New variants of SARS-CoV-2

Cantón, R., Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Gómez‐Pavón, J., del Castillo, J. M. G., Hernández‐Sampelayo, T., Delgado, M. C. M., Martín‐Sánchez, F. J., Martínez‐Sellés, M., et al. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/071.2021 · Cited by 65 · see citing works

Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia

小山, 幸., Kondo, K., Ueha, R., Kashiwadani, H., & Heinbockel, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168912 · Cited by 65 · see citing works

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world

Chavda, V. P., Yao, Q., Vora, L. K., Apostolopoulos, V., Patel, C. A., Bezbaruah, R., Patel, A., & Chen, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961198 · Cited by 62 · see citing works

A Simple Reverse Transcriptase PCR Melting-Temperature Assay To Rapidly Screen for Widely Circulating SARS-CoV-2 Variants

Banada, P. P., Green, R., Banik, S., Chopoorian, A., Streck, D. L., Jones, R., Chakravorty, S., & Alland, D. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-21 · Cited by 61 · see citing works

Development and application of therapeutic antibodies against COVID-19

Ning, L.-J., Abagna, H. B., Jiang, Q., Liu, S., & Huang, J. (2021) · International Journal on Biological Sciences · doi:10.7150/ijbs.59149 · Cited by 52 · see citing works

Five consecutive epidemiological waves of COVID-19: a population-based cross-sectional study on characteristics, policies, and health outcome

Amin, R., Sohrabi, M.-R., Zali, A., & Hannani, K. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07909-y · Cited by 59 · see citing works

A Narrative Review of COVID-19 Vaccines

Eroglu, B., Nuwarda, R. F., Ramzan, I., & Kayser, V. (2021) · Vaccines · doi:10.3390/vaccines10010062 · Cited by 58 · see citing works

Modeling COVID-19 dynamic using a two-strain model with vaccination

de León, U. A.-P., Avila-Vales, E. J., & Huang, K. (2022) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2022.111927 · Cited by 57 · see citing works

ViralFlow: A Versatile Automated Workflow for SARS-CoV-2 Genome Assembly, Lineage Assignment, Mutations and Intrahost Variant Detection

Dezordi, F. Z., Neto, A. M. D. S., Campos, T. D. L., Jerônimo, P. M. C., Aksenen, C. F., Almeida, S. P., Wallau, G. L., & on behalf of the Fiocruz COVID-19 Genomic Surveillance Network (2022) · Viruses · doi:10.3390/v14020217 · Cited by 56 · see citing works

Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B.1.617.2 in EnglandPreprint

Challen, R., Dyson, L., Overton, C. E., Guzman-Rincon, L. M., Hill, E. M., Stage, H. B., Brooks‐Pollock, E., Pellis, L., Scarabel, F., Pascall, D. J., et al. (2021) · medRxiv · doi:10.1101/2021.06.05.21258365 · Cited by 56 · see citing works

SARS-CoV-2 variants reveal features critical for replication in primary human cells

Pohl, M. O., Busnadiego, I., Kufner, V., Glas, I., Karakus, U., Schmutz, S., Zaheri, M., Abela, I. A., Trkola, A., Huber, M., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001006 · Cited by 54 · see citing works

Precision therapeutic targets for COVID-19

Krumm, Z. A., Lloyd, G. M., Francis, C. P., Nasif, L. H., Mitchell, D. A., Golde, T. E., Giasson, B. I., & Xia, Y. (2021) · Virology Journal · doi:10.1186/s12985-021-01526-y · Cited by 55 · see citing works

Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients

Okada, Y., Yoshimura, K., Toya, S., & Tsuchimochi, M. (2021) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2021.07.001 · Cited by 55 · see citing works

A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19

Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 55 · see citing works

Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis

Kumar, R., Srivastava, Y., Muthuramalingam, P., Singh, S. K., Verma, G., Tiwari, S., Tandel, N., Beura, S. K., Panigrahi, A. R., Maji, S., et al. (2023) · Viruses · doi:10.3390/v15040856 · Cited by 55 · see citing works

Insights into SARS-CoV-2 Persistence and Its Relevance

Desimmie, B. A., Raru, Y., Awadh, H., He, P., Teka, S., & Willenburg, K. S. (2021) · Viruses · doi:10.3390/v13061025 · Cited by 54 · see citing works

SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern

Lu, M., Chamblee, M., Zhang, Y., Ye, C., Dravid, P., Park, J., Mahesh, K., Trivedi, S., Murthy, S. S., Sharma, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110105119 · Cited by 54 · see citing works

Dynamics of a Stochastic Epidemic Model with Vaccination and Multiple Time‐Delays for COVID‐19 in the UAE

Alsakaji, H. J., Rihan, F. A., & Hashish, A. H. (2022) · Complexity · doi:10.1155/2022/4247800 · Cited by 52 · see citing works

Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2

Kamat, S., Kumari, M., & Jayabaskaran, C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.046 · Cited by 51 · see citing works

Predicting Mutational Effects on Receptor Binding of the Spike Protein of SARS-CoV-2 Variants

Bai, C., Wang, J., Chen, G., Zhang, H., An, K., Xu, P., Du, Y., Ye, R. D., Saha, A., Zhang, A., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07965 · Cited by 51 · see citing works

Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection

Okuya, K., Hattori, T., Saito, T., Takadate, Y., Sasaki, M., Furuyama, W., Marzi, A., Ohiro, Y., Konno, S., Hattori, T., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01553-21 · Cited by 51 · see citing works

NeutrobodyPlex—monitoring SARS-CoV-2 neutralizing immune responses using nanobodies

Wagner, T. R., Kaiser, P. D., Gramlich, M., Ostertag, E., Ruétalo, N., Junker, D., Häring, J., Traenkle, B., Becker, M., Dulovic, A., et al. (2021) · EMBO Reports · doi:10.15252/embr.202052325 · Cited by 49 · see citing works

Precision Medicine for COVID-19

DeMerle, K. M., Angus, D., & Seymour, C. W. (2021) · JAMA · doi:10.1001/jama.2021.5248 · Cited by 49 · see citing works

Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease

Todorović‐Raković, N., & Whitfield, J. R. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155637 · Cited by 48 · see citing works

Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection

Hariharan, V. N., Shin, M., Chang, C., O’Reilly, D., Biscans, A., Yamada, K., Guo, Z., Somasundaran, M., Tang, Q., Monopoli, K. R., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219523120 · Cited by 48 · see citing works

Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations

Helms, L., Marchiano, S., Stanaway, I. B., Hsiang, T.-Y., Juliar, B. A., Saini, S., Zhao, Y. T., Khanna, A., Menon, R., Alakwaa, F., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.154882 · Cited by 47 · see citing works

An Exploratory Study of Tweets about the SARS-CoV-2 Omicron Variant: Insights from Sentiment Analysis, Language Interpretation, Source Tracking, Type Classification, and Embedded URL Detection

Thakur, N., & Han, C. Y. (2022) · COVID · doi:10.3390/covid2080076 · Cited by 46 · see citing works

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants

Li, T., Han, X., Gu, C., Guo, H., Zhang, H., Wang, Y., Hu, C., Wang, K., Liu, F., Luo, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26539-7 · Cited by 45 · see citing works

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance

Chakraborty, C., Bhattacharya, M., & Sharma, A. R. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.006 · Cited by 45 · see citing works

Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria

Ozer, E. A., Simons, L. M., Adewumi, M. O., Fowotade, A., Omoruyi, E. C., Adeniji, J. A., Olayinka, O. A., Dean, T. J., Zayas, J. P., Bhimalli, P. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28317-5 · Cited by 45 · see citing works

Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic

Dhar, B. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-03918-7 · Cited by 45 · see citing works

Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants

Badraoui, R., Saoudi, M., Hamadou, W. S., Elkahoui, S., Siddiqui, A. J., Alam, M. J., Jamal, A., Adnan, M., Suliemen, A. M. E., Alreshidi, M. M., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15020129 · Cited by 44 · see citing works

First-Year Quantitative Assessment of the Multidimensional Impact of the COVID-19 Pandemic on Sustainable Development Goals

Elsamadony, M., Fujii, M., Ryo, M., Nerini, F. F., Kakinuma, K., & Kanae, S. (2021) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2022.133812 · Cited by 42 · see citing works

A wearable AIEgen-based lateral flow test strip for rapid detection of SARS-CoV-2 RBD protein and N protein

Zhang, G., Gao, Z., Zhang, J., Ou, H., Gao, H., Kwok, R. T. K., Ding, D., & Tang, B. Z. (2022) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2022.100740 · Cited by 42 · see citing works

Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll‐like receptors dictates pathophysiology of COVID‐19 disease

Vakil, M. K., Mansoori, Y., Al‐Awsi, G. R. L., Hosseinipour, A., Ahsant, S., Ahmadi, S., Ekrahi, M., Montaseri, Z., Pezeshki, B., Mohaghegh, P., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27849 · Cited by 42 · see citing works

Scabies in AIDS.

Orkin, M. (1993) · PubMed · Cited by 41 · see citing works

Review: SARS-CoV-2 infection in farmed minks – an overview of current knowledge on occurrence, disease and epidemiology

Pomorska‐Mól, M., Włodarek, J., Gogulski, M., & Rybska, M. (2021) · animal · doi:10.1016/j.animal.2021.100272 · Cited by 40 · see citing works

TEMPO: A transformer-based mutation prediction framework for SARS-CoV-2 evolution

Zhou, B., Zhou, H., Zhang, X., Xu, X., Chai, Y., Zheng, Z., Kot, A. C., & Zhou, Z. M. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106264 · Cited by 40 · see citing works

COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control

Buchy, P., Buisson, Y., Cintra, O. A. L., Dwyer, D. E., Nissen, M. D., de Lejarazu, R. O., & Petersen, E. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.045 · Cited by 40 · see citing works

Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment

Swain, S. S., Singh, S. R., Sahoo, A., Hussain, T., & Pati, S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1885495 · Cited by 39 · see citing works

Cross-Species Tropism and Antigenic Landscapes of Circulating SARS-CoV-2 Variants

Zhang, Y., Wei, M., Wu, Y., Wang, J., Hong, Y., Huang, Y., Yuan, L., Ma, J., Wang, K., Wang, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2022.110558 · Cited by 39 · see citing works

Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19

Lindner, H. A., Velásquez, S. Y., Thiel, M., & Kirschning, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602130 · Cited by 38 · see citing works

Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials

Takayama, S., Namiki, T., Odaguchi, H., Arita, R., Hisanaga, A., Mitani, K., & Ito, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.656246 · Cited by 38 · see citing works

Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program

Goswami, C. P., Sheldon, M., Bixby, C. J., Keddache, M. A., Bogdanowicz, A., Wang, Y., Schultz, J., McDevitt, J., LaPorta, J., Kwon, E., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07374-7 · Cited by 38 · see citing works

SARS-CoV-2 N501Y Introductions and Transmissions in Switzerland from Beginning of October 2020 to February 2021—Implementation of Swiss-Wide Diagnostic Screening and Whole Genome Sequencing

Cabecinhas, A. R. G., Roloff, T. C., Stange, M., Bertelli, C., Huber, M., Ramette, A., Chen, C., Nadeau, S., Gerth, Y., Yerly, S., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040677 · Cited by 37 · see citing works

Genetic variants of SARS-CoV-2 and its clinical implications

Lara, A. E., Díaz, G. E. F., Benítez, S. N. G., & Soca, P. E. M. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)

SARS-COV-2: INSIGHT INTO THE EMERGING GENETIC VARIANTS

Korsun, N., Trifonova, I. T., Dobrinov, V., Grigorova, I., Angelova, S. G., & Alexiev, I. (2022) · PROBLEMS of Infectious and Parasitic Diseases · doi:10.58395/pipd.v49i3.73

Are new genome variants detected in SARS-CoV-2 expected considering population dynamics in viruses?

Ergören, M. Ç., Tulay, P., & Dündar, M. (2021) · The EuroBiotech Journal · doi:10.2478/ebtj-2021-0001 · Cited by 2 · see citing works

Notable and Emerging Variants of SARS-CoV-2 Virus: A Quick Glance

Dholariya, S. J., Parchwani, D. N., Singh, R., Sonagra, A. D., Motiani, A., & Patel, D. D. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-00991-0 · Cited by 13 · see citing works

COVID Mutation and Effect on Vaccine

Tian, Z. (2022) · Applied economics and policy studies · doi:10.1007/978-981-19-0564-3_5